A novel bladder cancer urinary biomarker: can it go where no marker has gone before?
Publication
, Journal Article
Dobbs, RW; Abern, MR
Published in: Transl Androl Urol
March 2018
Duke Scholars
Published In
Transl Androl Urol
DOI
ISSN
2223-4691
Publication Date
March 2018
Volume
7
Issue
Suppl 1
Start / End Page
S96 / S97
Location
China
Related Subject Headings
- 3215 Reproductive medicine
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dobbs, R. W., & Abern, M. R. (2018). A novel bladder cancer urinary biomarker: can it go where no marker has gone before? Transl Androl Urol, 7(Suppl 1), S96–S97. https://doi.org/10.21037/tau.2018.01.04
Dobbs, Ryan W., and Michael R. Abern. “A novel bladder cancer urinary biomarker: can it go where no marker has gone before?” Transl Androl Urol 7, no. Suppl 1 (March 2018): S96–97. https://doi.org/10.21037/tau.2018.01.04.
Dobbs RW, Abern MR. A novel bladder cancer urinary biomarker: can it go where no marker has gone before? Transl Androl Urol. 2018 Mar;7(Suppl 1):S96–7.
Dobbs, Ryan W., and Michael R. Abern. “A novel bladder cancer urinary biomarker: can it go where no marker has gone before?” Transl Androl Urol, vol. 7, no. Suppl 1, Mar. 2018, pp. S96–97. Pubmed, doi:10.21037/tau.2018.01.04.
Dobbs RW, Abern MR. A novel bladder cancer urinary biomarker: can it go where no marker has gone before? Transl Androl Urol. 2018 Mar;7(Suppl 1):S96–S97.
Published In
Transl Androl Urol
DOI
ISSN
2223-4691
Publication Date
March 2018
Volume
7
Issue
Suppl 1
Start / End Page
S96 / S97
Location
China
Related Subject Headings
- 3215 Reproductive medicine
- 3202 Clinical sciences